
ZMYND8 Boosts HER2 Antibody Resistance via Lipid-IL-27
In a groundbreaking study poised to shift paradigms in breast cancer therapy, researchers have uncovered a pivotal molecular mechanism driving resistance to HER2-targeted antibody treatments. The work, recently published in Nature Communications, …